Erin Parry, MD PhD

Physician-scientist, Lymphoma oncologist @DanaFarber | Tweets are my own and not medical advice. #Lymphoma

[Romain Guieze @RomainGuieze]

Happy to share the results of our first #richter trial now published @NatureComms

https://t.co/tfTQQmTmp8

[Lili Wang Lab @LiliWangLab]

Excited to share our latest publication from the Lili Wang lab! by Prajish Iyer et al.🌟 MGA deletion drives Richter’s transformation by modulating mitochondrial OXPHOS, highlighting new therapeutic avenues. @DanilovLab @CllSociety
https://t.co/R5nV8eIQYz

[AACR @AACR]

#AACRlymph24 cochair Ari M. Melnick, Sandrine Roulland, and Erin M. Parry discussed "Lymphoma Clonal Precursors and Transformation" in a plenary session at the Fourth AACR International Meeting on Advances in Malignant Lymphoma. @LabMelnick @SRoulland @ErinMParry

[ASH @ASH_hematology]

🔬Are you an early-career researcher ready to take the next step in your research career? Apply for ASH & @EHA_Hematology's #TRTH program! Read the testimonials to see what past participants had to say about their experiences! Apply by June 20: https://t.co/2lh2CSRj8G
#hematology

[Erin Parry, MD PhD @ErinMParry]

@SamHoffmanMed @VanAllenLab Congrats!!

[Erin Parry, MD PhD @ErinMParry]

@DSilverbush Thanks Dana!

[Erin Parry, MD PhD @ErinMParry]

@LiliWangLab Thanks Lili!

[Erin Parry, MD PhD @ErinMParry]

@LiliWangLab Congrats Lili!!

[Erin Parry, MD PhD @ErinMParry]

@DrMDavids @LLSusa @DanaFarber @rosslevinemd Congrats!!

[Lachelle Dawn @Lachelle_Dawn]

#ASH23 is about running from a meeting in the Marriot all the way to room 28 in the conference center to see @beckyzon rock her presentation on CHIP and VTE in the UKBiobank

[Dana-Farber News @DanaFarberNews]

At #ASH23, Reid Merryman, MD @DanaFarber reveals results from a pilot study that uses circulating tumor DNA to reliably predict relapse in patients with diffuse large B-cell lymphoma (#DLBCL).
Press release: https://t.co/PmiFBXNE47

[Rémy Duléry @RemyDulery]

#ASH23 - Abstract 223
Outstanding presentation by @Dr_KatieM 👏🏻👏🏻👏🏻

Response to axi-cel is associated with:
✅The presence of > 0.5% circulating B-cells at baseline
✅Higher ALC/AMC at baseline
✅Enrichment of clonally expanded
CD8+ TEM cells in IP
#CARTcell

[Matthew Davids, MD, MMSc @DrMDavids]

⁦@inhyeahn⁩ from ⁦@DanaFarber⁩ presenting at #iwcll2023 on one of the largest datasets ever reported for BTKi resistance mechanisms in CLL ⁦⁦@iwCLL⁩

[iwCLL @iwCLL]

Congratulations to Dr. Susan O’Brien (@UCIrvineHealth) and Dr. Catherine Wu (@DanaFaber), recipients of the iwCLL Binet-Rai Medals for outstanding contributions to CLL research at #iwCLL2023

[Erin Parry, MD PhD @ErinMParry]

Had a great time at #iwCLL2023 sharing our work @RomainGuieze @lesh_lab @getz_lab Stilgenbauer and Wu in an amazing genomics session! Fascinating talks by Cindy Hahn @FerranNadeu @PaulineRobbe

[Romain Guieze @RomainGuieze]

⁦@iwCLL⁩2023 So many great contributions to the #Richter biology this year ! Bravo to ⁦@ErinMParry⁩ and ⁦@FerranNadeu⁩ for such great talks !

[Erin Parry, MD PhD @ErinMParry]

Congrats Elisa!

[Elisa ten Hacken @etenhacken]

#AndJustLikeThat 🌟the ten Hacken lab is officially live from @WeillCornell NYC! 🌟

Join me in this new exciting adventure if you are interested in understanding chronic lymphocytic leukemia and Richter’s syndrome through mouse modeling (and more!). Recruiting at all levels!

[Dana-Farber @DanaFarber]

The story behind Venetoclax, a new cancer therapy, started nearly 40 years ago. How it went from the discovery of a protein to a game-changing cancer drug is a story of persistence and momentum and the first episode of season two of the Unraveled podcast. https://t.co/hgSujTZijb

[Dana-Farber News @DanaFarberNews]

During an early morning session here at #ASH22, there’s an overflow crowd for @DanaFarber Caron Jacobson’s, MD, MMSc, presentation on her findings from her investigator-initiated study of CAR T-cell therapy for CNS lymphoma. There’s not an empty seat in the ballroom.

[Christine Ryan, MD @ChristineRyanMD]

This was all only possible because of the study’s lead investigator and my incredible mentor @DrMDavids. Many, many thanks to him for the generous opportunity to present these results yesterday! #ASH22 @DanaFarber @DanaFarberNews

[Blood Cancer Discovery @BCD_AACR]

In vivo modeling of #CLL transformation to #Richtersyndrome reveals convergent evolutionary paths and therapeutic vulnerabilities, by @etenhacken et al.
https://t.co/FXuwqrlAsO
@DanaFarberNews @DanaFarber @harvardmed #chroniclymphocyticleukemia